New Therapies and Biomarkers for Chagas Infection

NCT03981523 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

450

Enrollment

OTHER

Sponsor class

Conditions

Trypanosoma Cruzi Infection
Chagas Disease

Interventions

DRUG: Benznidazole
DRUG: Nifurtimox

Sponsor

University of Texas, El Paso

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]